Next Article in Journal
Valorization Pathway for Grape Pruning and Pomace Waste from the Wine Industry: Energy and Non-Energy Applications
Previous Article in Journal
Antimicrobial Activity of Copper(II), Nickel(II) and Zinc(II) Complexes with Semicarbazone and Thiosemicarbazone Ligands Derived from Substituted Salicylaldehydes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 30
Issue 11
10.3390/molecules30112330
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Molecules 2022, 27(8), 2474.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Majid et al. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474

by
Muhammad Majid
1,
Anam Farhan
2,
Muhammad Imran Asad
3,
Muhammad Rashid Khan
4,
Syed Shams ul Hassan
5,6,*,
Ihsan-ul Haq
3,* and
Simona Bungau
7,*
1
Faculty of Pharmacy, Capital University of Science and Technology, Islamabad 44000, Pakistan
2
Department of Biology, School of Science and Engineering, Lahore University of Management Sciences, Lahore 54810, Pakistan
3
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 44000, Pakistan
4
Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 44000, Pakistan
5
Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
6
Department of Natural Product Chemistry, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
7
Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(11), 2330; https://doi.org/10.3390/molecules30112330
Submission received: 8 April 2025 / Accepted: 5 May 2025 / Published: 27 May 2025
Versions Notes
The journal retracts the article “An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies” [1] cited above.
Following publication, concerns were brought to the attention of the publisher regarding a element duplications contained with images presented in this article [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that confirmed highly similar elements between the panels “Control—12 h” and “NA—12 h” presented in Figure 3A. While the authors cooperated within the investigation, they were unable to satisfactorily explain the overlap nor provide material deemed satisfactory by the Editorial Board to verify the integrity of the images. As a result, the Editorial Board has lost confidence in the integrity of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Molecules.
The corresponding authors did not agree to this retraction. The remaining authors did not provide a comment on this decision.

Reference

  1. Majid, M.; Farhan, A.; Asad, M.I.; Khan, M.R.; Hassan, S.S.u.; Haq, I.-u.; Bungau, S. RETRACTED: An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Majid, M.; Farhan, A.; Asad, M.I.; Khan, M.R.; Hassan, S.S.u.; Haq, I.-u.; Bungau, S. RETRACTED: Majid et al. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474. Molecules 2025, 30, 2330. https://doi.org/10.3390/molecules30112330

AMA Style

Majid M, Farhan A, Asad MI, Khan MR, Hassan SSu, Haq I-u, Bungau S. RETRACTED: Majid et al. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474. Molecules. 2025; 30(11):2330. https://doi.org/10.3390/molecules30112330

Chicago/Turabian Style

Majid, Muhammad, Anam Farhan, Muhammad Imran Asad, Muhammad Rashid Khan, Syed Shams ul Hassan, Ihsan-ul Haq, and Simona Bungau. 2025. "RETRACTED: Majid et al. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474" Molecules 30, no. 11: 2330. https://doi.org/10.3390/molecules30112330

APA Style

Majid, M., Farhan, A., Asad, M. I., Khan, M. R., Hassan, S. S. u., Haq, I.-u., & Bungau, S. (2025). RETRACTED: Majid et al. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from Ipomoea batatas through In Vitro, In Silico, and In Vivo Studies. Molecules 2022, 27, 2474. Molecules, 30(11), 2330. https://doi.org/10.3390/molecules30112330

Article Metrics

Back to TopTop